Danaher Corporation is an American globally diversified conglomerate founded by brothers Stephen and Mitchell Rales in 1984. Headquartered in Washington, D.C., the company designs, manufactures, and markets medical, industrial, and commercial products and services.
Company profile
Ticker
DHR
Exchange
Website
CEO
Rainer Blair
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Roper • Fortive • Ametek • Sensata Technologies Holding • Keysight • MKS Instruments • Cognex • Hurco Companies • Sypris Solutions • Mesa Laboratories ...
Former names
DMG INC
SEC CIK
Corporate docs
Subsidiaries
AB Sciex Finance B.V. • AB Sciex LLC • AB Sciex Pte. Ltd. • Abcam Limited • Alaska Blocker Corp. • Aldevron LLC • BC Distribution B.V. • Beckman Coulter Biomedical GmbH • Beckman Coulter Biotechnology (Suzhou) Co., Ltd. • Beckman Coulter Canada LP ...
IRS number
591995548
DHR stock data
Latest filings (excl ownership)
SD
Conflict minerals disclosure
16 May 24
8-K
Submission of Matters to a Vote of Security Holders
8 May 24
8-K
Danaher Reports First Quarter 2024 Results
22 Apr 24
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
22 Apr 24
10-Q
2024 Q1
Quarterly report
22 Apr 24
PX14A6G
Letter to shareholders
11 Apr 24
S-3ASR
Automatic shelf registration
1 Apr 24
25-NSE
Exchange delisting
1 Apr 24
ARS
2023 FY
Annual report to shareholders
27 Mar 24
DEFA14A
Additional proxy soliciting materials
27 Mar 24
Transcripts
DHR
Earnings call transcript
2024 Q1
23 Apr 24
DHR
Earnings call transcript
2023 Q4
30 Jan 24
DHR
Earnings call transcript
2023 Q3
24 Oct 23
DHR
Earnings call transcript
2023 Q2
25 Jul 23
DHR
Earnings call transcript
2023 Q1
25 Apr 23
DHR
Earnings call transcript
2022 Q4
24 Jan 23
DHR
Earnings call transcript
2022 Q3
20 Oct 22
DHR
Earnings call transcript
2022 Q2
21 Jul 22
DHR
Earnings call transcript
2022 Q1
21 Apr 22
DHR
Earnings call transcript
2021 Q4
27 Jan 22
Latest ownership filings
Financial summary
Quarter (USD) | Mar 24 | Dec 23 | Sep 23 | Jun 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 7.03 bn | 7.03 bn | 7.03 bn | 7.03 bn | 7.03 bn | 7.03 bn |
Cash burn (monthly) | (no burn) | 29.00 mm | (no burn) | (no burn) | (no burn) | (no burn) |
Cash used (since last report) | n/a | 58.01 mm | n/a | n/a | n/a | n/a |
Cash remaining | n/a | 6.97 bn | n/a | n/a | n/a | n/a |
Runway (months of cash) | n/a | 240.4 | n/a | n/a | n/a | n/a |
Institutional ownership, Q1 2024
77.1% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 2072 |
Opened positions | 443 |
Closed positions | 161 |
Increased positions | 747 |
Reduced positions | 615 |
13F shares | Current |
---|---|
Total value | 130.05 tn |
Total shares | 570.89 mm |
Total puts | 3.96 mm |
Total calls | 3.53 mm |
Total put/call ratio | 1.1 |
Largest owners | Shares | Value |
---|---|---|
Vanguard | 60.11 mm | $15.01 tn |
BLK Blackrock | 49.68 mm | $12.41 tn |
STT State Street | 27.76 mm | $6.94 tn |
Wellington Management | 26.72 mm | $6.67 tn |
FMR | 22.22 mm | $5.55 tn |
MS Morgan Stanley | 16.50 mm | $4.12 tn |
T. Rowe Price | 16.15 mm | $4.03 bn |
Capital International Investors | 15.08 mm | $3.77 tn |
Geode Capital Management | 12.91 mm | $3.21 tn |
JPM JPMorgan Chase & Co. | 10.98 mm | $2.74 tn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
16 May 24 | Blair Rainer | Common Stock | Sell | Dispose S | No | Yes | 265 | 9,005 | 2.39 mm | 106,990 |
15 May 24 | Sabeti Pardis C | Common Stock | Grant | Acquire A | No | No | 0 | 390 | 0.00 | 5,282.977 |
15 May 24 | Sabeti Pardis C | Director stock option Common Stock | Grant | Acquire A | No | No | 263.46 | 1,081 | 284.80 k | 1,081 |
15 May 24 | Zerhouni Elias A. | Common Stock | Grant | Acquire A | No | No | 0 | 390 | 0.00 | 34,194.417 |
15 May 24 | Zerhouni Elias A. | Director stock option Common Stock | Grant | Acquire A | No | No | 263.46 | 1,081 | 284.80 k | 1,081 |
15 May 24 | A Shane Sanders | Common Stock | Grant | Acquire A | No | No | 0 | 390 | 0.00 | 3,270.176 |
15 May 24 | A Shane Sanders | Director stock option Common Stock | Grant | Acquire A | No | No | 263.46 | 1,081 | 284.80 k | 1,081 |
15 May 24 | Dewan Feroz | Common Stock | Grant | Acquire A | No | No | 0 | 390 | 0.00 | 2,222.986 |
15 May 24 | Dewan Feroz | Director stock option Common Stock | Grant | Acquire A | No | No | 263.46 | 1,081 | 284.80 k | 1,081 |
News
10 Health Care Stocks With Whale Alerts In Today's Session
28 May 24
$1000 Invested In Danaher 10 Years Ago Would Be Worth This Much Today
13 May 24
Danaher Launches Collaboration With Johns Hopkins University Aiming To Improve Neurological Diagnosis
9 May 24
How Is The Market Feeling About Danaher?
6 May 24
$100 Invested In This Stock 10 Years Ago Would Be Worth $500 Today
3 May 24
Press releases
Danaher to Present at Bank of America Securities Healthcare Conference
7 May 24
Danaher Announces Quarterly Dividend
7 May 24
Curiox Biosystems and Beckman Coulter Life Sciences Announce a Partnership Combining C-FREE™ Technology with DURA Innovations for Hands-Free Washed Sample Preparation for Flow Cytometry
3 May 24
Danaher Reports First Quarter 2024 Results
23 Apr 24
Danaher Schedules First Quarter 2024 Earnings Conference Call
21 Mar 24